指南与共识免疫规划卫生政策与健康促进

ACIP关于COVID-19疫苗初始供应分配的临时建议

The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
指南 / 共识 · MMWR Morb Mortal Wkly Rep · 2020-12-11

ACIP建议,当COVID-19疫苗获FDA授权并由ACIP推荐时,在疫苗接种计划初始阶段(1a期),应向医护人员和长期护理机构居民提供疫苗接种。该临时建议可能根据III期临床试验的额外安全性和有效性数据以及FDA紧急使用授权条件在未来几周内更新。

要点

  • ACIP建议COVID-19疫苗初始阶段优先为医护人员接种。
  • ACIP建议长期护理机构居民同样在初始阶段优先接种。
  • 该建议为临时性,将随III期数据和FDA授权条件更新。

核心结论

  • 当COVID-19疫苗获FDA授权并由ACIP推荐时,医护人员和长期护理机构居民应在初始阶段(1a期)优先接种。

研究设计与样本

  • 建议基于SARS-CoV-2流行病学科学证据、疫苗接种计划实施和伦理原则的审议。

主要发现

  • 即使一个或多个候选疫苗获紧急使用授权,国家疫苗接种计划最初几个月的需求预计超过供应。

关键数值与推荐

  • 初始阶段(1a期)优先人群包括医护人员和长期护理机构居民。

临床怎么用

  • 联邦、州和地方辖区可依据此临时建议规划COVID-19疫苗初始剂量分配。
  • 在疫苗获FDA授权并由ACIP推荐后,优先为医护人员和长期护理机构居民接种。

局限性

  • 该建议为临时性,可能根据III期临床试验额外安全性和有效性数据以及FDA紧急使用授权条件更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The emergence of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has led to a global pandemic that has disrupted all sectors of society. Less than 1 year after the SARS-CoV-2 genome was first sequenced, an application* for Emergency Use Authorization for a candidate vaccine has been filed with the Food and Drug Administration (FDA). However, even if one or more vaccine candidates receive authorization for emergency use, demand for COVID-19 vaccine is expected to exceed supply during the first months of the national vaccination program. The Advisory Committee on Immunization Practices (ACIP) advises CDC on population groups and circumstances for vaccine use.† ACIP convened on December 1, 2020, in advance of the completion of FDA's review of the Emergency Use Authorization application, to provide interim guidance to federal, state, and local jurisdictions on allocation of initial doses of COVID-19 vaccine. ACIP recommended that, when a COVID-19 vaccine is authorized by FDA and recommended by ACIP, both 1) health care personnel§ and 2) residents of long-term care facilities (LTCFs)¶ be offered vaccination in the initial phase of the COVID-19 vaccination program (Phase 1a**).†† In its deliberations, ACIP considered scientific evidence of SARS-CoV-2 epidemiology, vaccination program implementation, and ethical principles.§§ The interim recommendation might be updated over the coming weeks based on additional safety and efficacy data from phase III clinical trials and conditions of FDA Emergency Use Authorization.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Dooling K, McClung N, Chamberland M, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33301429. doi:10.15585/mmwr.mm6949e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。